<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35477657</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>08</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1525-0024</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>8</Issue><PubDate><Year>2022</Year><Month>Aug</Month><Day>03</Day></PubDate></JournalIssue><Title>Molecular therapy : the journal of the American Society of Gene Therapy</Title><ISOAbbreviation>Mol Ther</ISOAbbreviation></Journal><ArticleTitle>Boosting the peripheral immune response in the skeletal muscles improved motor function in ALS transgenic mice.</ArticleTitle><Pagination><StartPage>2760</StartPage><EndPage>2784</EndPage><MedlinePgn>2760-2784</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ymthe.2022.04.018</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1525-0016(22)00248-9</ELocationID><Abstract><AbstractText>Monocyte chemoattractant protein-1 (MCP1) is one of the most powerful pro-inflammatory chemokines. However, its signaling is pivotal in driving injured axon and muscle regeneration. We previously reported that MCP1 is more strongly upregulated in the nervous system of slow-progressing than fast-progressing SOD1<sup>G93A</sup> mice, the latter showing a poor immune response and eventual massive nerve and muscle degeneration. To assess the MCP1-mediated therapeutic role, we boosted the chemokine along the motor unit of the two SOD1<sup>G93A</sup> models through a single intramuscular injection of a scAAV9 vector engineered with the Mcp1 gene. We provided direct evidence underlying the pivotal role of the immune response in driving skeletal muscle regeneration and thus the speed of ALS progression. The comparative study performed in fast- and slow-progressing SOD1<sup>G93A</sup> mice spotlights the nature and temporal activation of the inflammatory response as limiting factors to preserve the periphery and interfere with the disease course. In addition, we recorded a novel pleiotropic role of MCP1 in promoting peripheral axon regeneration and modulating neuroinflammation, ultimately preventing neurodegeneration. Altogether, these observations highlight the immune response as a key determinant for disease variability and proffer a reasonable explanation for the failure of systemic immunomodulatory treatments, suggesting new potential strategies to hamper ALS progression.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 The Author(s). Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Trolese</LastName><ForeName>Maria Chiara</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Neurobiology, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri Mario Negri IRCCS, Via Mario Negri 2, 20156 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scarpa</LastName><ForeName>Carlotta</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Neurobiology, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri Mario Negri IRCCS, Via Mario Negri 2, 20156 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melfi</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Neurobiology, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri Mario Negri IRCCS, Via Mario Negri 2, 20156 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fabbrizio</LastName><ForeName>Paola</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Neurobiology, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri Mario Negri IRCCS, Via Mario Negri 2, 20156 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sironi</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Neurobiology, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri Mario Negri IRCCS, Via Mario Negri 2, 20156 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rossi</LastName><ForeName>Martina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Neurobiology, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri Mario Negri IRCCS, Via Mario Negri 2, 20156 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bendotti</LastName><ForeName>Caterina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Neurobiology, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri Mario Negri IRCCS, Via Mario Negri 2, 20156 Milan, Italy. Electronic address: caterina.bendotti@marionegri.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nardo</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Neurobiology, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri Mario Negri IRCCS, Via Mario Negri 2, 20156 Milan, Italy. Electronic address: giovanni.nardo@marionegri.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mol Ther</MedlineTA><NlmUniqueID>100890581</NlmUniqueID><ISSNLinking>1525-0016</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001369" MajorTopicYN="N">Axons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007109" MajorTopicYN="N">Immunity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018482" MajorTopicYN="N">Muscle, Skeletal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009416" MajorTopicYN="N">Nerve Regeneration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">immune cells</Keyword><Keyword MajorTopicYN="N">motor neuron</Keyword><Keyword MajorTopicYN="N">mouse models</Keyword><Keyword MajorTopicYN="N">myogenesis</Keyword><Keyword MajorTopicYN="N">satellite cells</Keyword><Keyword MajorTopicYN="N">skeletal muscle</Keyword></KeywordList><CoiStatement>Declaration of interests The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>4</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>4</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>28</Day><Hour>5</Hour><Minute>22</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35477657</ArticleId><ArticleId IdType="pmc">PMC9372324</ArticleId><ArticleId IdType="doi">10.1016/j.ymthe.2022.04.018</ArticleId><ArticleId IdType="pii">S1525-0016(22)00248-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hardiman O., Al-Chalabi A., Chio A., Corr E.M., Logroscino G., Robberecht W., Shaw P.J., Simmons Z., van den Berg L.H. Amyotrophic lateral sclerosis. Nat. Rev. Dis. Prim. 2017;3:17071. doi: 10.1038/nrdp.2017.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Masrori P., Van Damme P. Amyotrophic lateral sclerosis: a clinical review. Eur. J. Neurol. 2020;27:1918&#x2013;1929. doi: 10.1111/ene.14393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14393</ArticleId><ArticleId IdType="pmc">PMC7540334</ArticleId><ArticleId IdType="pubmed">32526057</ArticleId></ArticleIdList></Reference><Reference><Citation>Penco S., Lunetta C., Mosca L., Maestri E., Avemaria F., Tarlarini C., Patrosso M.C., Marocchi A., Corbo M. Phenotypic heterogeneity in a SOD1 G93D Italian ALS family: an example of human model to study a complex disease. J.&#xa0;Mol. Neurosci. 2011;44:25&#x2013;30. doi: 10.1007/s12031-010-9480-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-010-9480-4</ArticleId><ArticleId IdType="pubmed">21120636</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xe9;gal L., Vanopdenbosch L., Tilkin P., Van den Bosch L., Thijs V., Sciot R., Robberecht W. The G93C mutation in superoxide dismutase 1: clinicopathologic phenotype and prognosis. Arch. Neurol. 2006;63:262&#x2013;267. doi: 10.1001/archneur.63.2.262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.63.2.262</ArticleId><ArticleId IdType="pubmed">16476815</ArticleId></ArticleIdList></Reference><Reference><Citation>Ticozzi N., Silani V. Neurodegenerative Diseases. Springer International Publishing); 2018. Genotypic and phenotypic heterogeneity in amyotrophic lateral sclerosis; pp. 279&#x2013;295.</Citation></Reference><Reference><Citation>Bendotti C., Bonetto V., Pupillo E., Logroscino G., Al-Chalabi A., Lunetta C., Riva N., Mora G., Lauria G., Weishaupt J.H., et al. Focus on the heterogeneity of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Frontotemporal Degener. 2020;21:485&#x2013;495. doi: 10.1080/21678421.2020.1779298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1779298</ArticleId><ArticleId IdType="pubmed">32583689</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejzini R., Flynn L.L., Pitout I.L., Fletcher S., Wilton S.D., Akkari P.A. ALS genetics, mechanisms, and therapeutics: where are we now? Front. Neurosci. 2019;13:1310. doi: 10.3389/fnins.2019.01310.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01310</ArticleId><ArticleId IdType="pmc">PMC6909825</ArticleId><ArticleId IdType="pubmed">31866818</ArticleId></ArticleIdList></Reference><Reference><Citation>Rouaux C., Panteleeva I., Ren&#xe9; F., Gonzalez de Aguilar J.-L., Echaniz-Laguna A., Dupuis L., Menger Y., Boutillier A.L., Loeffler J.P. Sodium valproate exerts neuroprotective effects in&#xa0;vivo through CREB-binding protein-dependent mechanisms but does not improve survival in an amyotrophic lateral sclerosis mouse model. J.&#xa0;Neurosci. 2007;27:5535&#x2013;5545. doi: 10.1523/jneurosci.1139-07.2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/jneurosci.1139-07.2007</ArticleId><ArticleId IdType="pmc">PMC6672753</ArticleId><ArticleId IdType="pubmed">17522299</ArticleId></ArticleIdList></Reference><Reference><Citation>Gould T.W., Buss R.R., Vinsant S., Prevette D., Sun W., Knudson C.M., Milligan C.E., Oppenheim R.W., et al. Complete dissociation of motor neuron death from motor dysfunction by Bax deletion in a mouse model of ALS. J.&#xa0;Neurosci. 2006;26:8774&#x2013;8786. doi: 10.1523/jneurosci.2315-06.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/jneurosci.2315-06.2006</ArticleId><ArticleId IdType="pmc">PMC6674380</ArticleId><ArticleId IdType="pubmed">16928866</ArticleId></ArticleIdList></Reference><Reference><Citation>Moloney E.B., de Winter F., Verhaagen J. ALS as a distal axonopathy: molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease. Front. Neurosci. 2014;8:252. doi: 10.3389/fnins.2014.00252.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2014.00252</ArticleId><ArticleId IdType="pmc">PMC4132373</ArticleId><ArticleId IdType="pubmed">25177267</ArticleId></ArticleIdList></Reference><Reference><Citation>Dadon-Nachum M., Melamed E., Offen D. The &#x201c;dying-back&#x201d; phenomenon of motor neurons in ALS. J.&#xa0;Mol. Neurosci. 2011;43:470&#x2013;477. doi: 10.1007/s12031-010-9467-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-010-9467-1</ArticleId><ArticleId IdType="pubmed">21057983</ArticleId></ArticleIdList></Reference><Reference><Citation>Gentile F., Scarlino S., Falzone Y.M., Lunetta C., Tremolizzo L., Quattrini A., Riva N. The peripheral nervous system in amyotrophic lateral sclerosis: opportunities for translational research. Front. Neurosci. 2019;13:601. doi: 10.3389/fnins.2019.00601.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00601</ArticleId><ArticleId IdType="pmc">PMC6603245</ArticleId><ArticleId IdType="pubmed">31293369</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiot A., Lobsiger C.S., Boill&#xe9;e S. New insights on the disease contribution of neuroinflammation in amyotrophic lateral sclerosis. Curr. Opin. Neurol. 2019;32:764&#x2013;770. doi: 10.1097/wco.0000000000000729.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/wco.0000000000000729</ArticleId><ArticleId IdType="pubmed">31306211</ArticleId></ArticleIdList></Reference><Reference><Citation>Thonhoff J.R., Simpson E.P., Appel S.H. Neuroinflammatory mechanisms in amyotrophic lateral sclerosis pathogenesis. Curr. Opin. Neurol. 2018;31:635&#x2013;639. doi: 10.1097/wco.0000000000000599.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/wco.0000000000000599</ArticleId><ArticleId IdType="pubmed">30048339</ArticleId></ArticleIdList></Reference><Reference><Citation>Dibaj P., Steffens H., Zsch&#xfc;ntzsch J., Nadrigny F., Schomburg E.D., Kirchhoff F., Neusch C. In&#xa0;Vivo imaging reveals distinct inflammatory activity of CNS microglia versus PNS macrophages in a mouse model for ALS. PLoS One. 2011;6:e17910. doi: 10.1371/journal.pone.0017910.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0017910</ArticleId><ArticleId IdType="pmc">PMC3060882</ArticleId><ArticleId IdType="pubmed">21437247</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu I.M., Phatnani H., Kuligowski M., Tapia J.C., Carrasco M.A., Zhang M., Maniatis T., Carroll M.C. Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. Proc. Natl. Acad. Sci. U&#xa0;S&#xa0;A. 2009;106:20960&#x2013;20965. doi: 10.1073/pnas.0911405106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0911405106</ArticleId><ArticleId IdType="pmc">PMC2791631</ArticleId><ArticleId IdType="pubmed">19933335</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng B., Lv W., Duan W., Liu Y., Li Z., Ma Y., Zhang G., Song X., Cui C., Qi X., Li C. Progressive degeneration and inhibition of peripheral nerve regeneration in the SOD1-G93A mouse model of amyotrophic lateral sclerosis. Cell. Physiol. Biochem. 2018;46:2358&#x2013;2372. doi: 10.1159/000489627.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000489627</ArticleId><ArticleId IdType="pubmed">29742495</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Dyke J.M., Smit-Oistad I.M., Macrander C., Krakora D., Meyer M.G., Suzuki M. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS) Exp. Neurol. 2016;277:275&#x2013;282. doi: 10.1016/j.expneurol.2016.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2016.01.008</ArticleId><ArticleId IdType="pmc">PMC4762214</ArticleId><ArticleId IdType="pubmed">26775178</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaudet A.D., Popovich P.G., Ramer M.S. Wallerian degeneration: gaining perspective on inflammatory events after peripheral nerve injury. J.&#xa0;Neuroinflammation. 2011;8:110. doi: 10.1186/1742-2094-8-110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-8-110</ArticleId><ArticleId IdType="pmc">PMC3180276</ArticleId><ArticleId IdType="pubmed">21878126</ArticleId></ArticleIdList></Reference><Reference><Citation>Sass F.A., Fuchs M., Pumberger M., Geissler S., Duda G.N., Perka C., Schmidt-Bleek K. Immunology guides skeletal muscle regeneration. Int. J. Mol. Sci. 2018;19:835. doi: 10.3390/ijms19030835.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19030835</ArticleId><ArticleId IdType="pmc">PMC5877696</ArticleId><ArticleId IdType="pubmed">29534011</ArticleId></ArticleIdList></Reference><Reference><Citation>Schreiber S., Schreiber F., Garz C., Debska-Vielhaber G., Assmann A., Perosa V., Petri S., Dengler R., Nestor P., Vielhaber S. Toward in&#xa0;vivo determination of peripheral nervous system immune activity in amyotrophic lateral sclerosis. Muscle Nerve. 2019;59:567&#x2013;576. doi: 10.1002/mus.26444.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26444</ArticleId><ArticleId IdType="pubmed">30734322</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyon M.S., Wosiski-Kuhn M., Gillespie R., Caress J., Milligan C. Inflammation, Immunity, and amyotrophic lateral sclerosis: I. Etiology and pathology. Muscle Nerve. 2019;59:10&#x2013;22. doi: 10.1002/mus.26289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26289</ArticleId><ArticleId IdType="pubmed">29979464</ArticleId></ArticleIdList></Reference><Reference><Citation>Wosiski-Kuhn M., Lyon M.S., Caress J., Milligan C. Inflammation, immunity, and amyotrophic lateral sclerosis: II. immune-modulating therapies. Muscle Nerve. 2019;59:23&#x2013;33. doi: 10.1002/mus.26288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26288</ArticleId><ArticleId IdType="pubmed">29979478</ArticleId></ArticleIdList></Reference><Reference><Citation>Marino M., Papa S., Crippa V., Nardo G., Peviani M., Cheroni C., Trolese M.C., Lauranzano E., Bonetto V., Poletti A., et al. Differences in protein quality control correlate with phenotype variability in 2 mouse models of familial amyotrophic lateral sclerosis. Neurobiol. Aging. 2015;36:492&#x2013;504. doi: 10.1016/j.neurobiolaging.2014.06.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.06.026</ArticleId><ArticleId IdType="pubmed">25085783</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardo G., Trolese M.C., Tortarolo M., Vallarola A., Freschi M., Pasetto L., Bonetto V., Bendotti C. New insights on the mechanisms of disease course variability in ALS from mutant SOD1 mouse models. Brain Pathol. 2016;26:237&#x2013;247. doi: 10.1111/bpa.12351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12351</ArticleId><ArticleId IdType="pmc">PMC8029191</ArticleId><ArticleId IdType="pubmed">26780365</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardo G., Trolese M.C., de Vito G., Cecchi R., Riva N., Dina G., Heath P.R., Quattrini A., Shaw P.J., Piazza V., Bendotti C. Immune response in peripheral axons delays disease progression in SOD1G93A mice. J.&#xa0;Neuroinflammation. 2016;13:261. doi: 10.1186/s12974-016-0732-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0732-2</ArticleId><ArticleId IdType="pmc">PMC5055725</ArticleId><ArticleId IdType="pubmed">27717377</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallarola A., Sironi F., Tortarolo M., Gatto N., De Gioia R., Pasetto L., De Paola M., Mariani A., Ghosh S., Watson R., et al. RNS60 exerts therapeutic effects in the SOD1 ALS mouse model through protective glia and peripheral nerve rescue. J.&#xa0;Neuroinflammation. 2018;15:65. doi: 10.1186/s12974-018-1101-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-018-1101-0</ArticleId><ArticleId IdType="pmc">PMC5833072</ArticleId><ArticleId IdType="pubmed">29495962</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardo G., Iennaco R., Fusi N., Heath P.R., Marino M., Trolese M.C., Ferraiuolo L., Lawrence N., Shaw P.J., Bendotti C. Transcriptomic indices of fast and slow disease progression in two mouse models of amyotrophic lateral sclerosis. Brain. 2013;136:3305&#x2013;3332. doi: 10.1093/brain/awt250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awt250</ArticleId><ArticleId IdType="pubmed">24065725</ArticleId></ArticleIdList></Reference><Reference><Citation>Shireman P.K., Contreras-Shannon V., Ochoa O., Karia B.P., Michalek J.E., McManus L.M. MCP-1 deficiency causes altered inflammation with impaired skeletal muscle regeneration. J.&#xa0;Leukoc. Biol. 2007;81:775&#x2013;785. doi: 10.1189/jlb.0506356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.0506356</ArticleId><ArticleId IdType="pubmed">17135576</ArticleId></ArticleIdList></Reference><Reference><Citation>Siebert H., Sachse A., Kuziel W.A., Maeda N., Br&#xfc;ck W. The chemokine receptor CCR2 is involved in macrophage recruitment to the injured peripheral nervous system. J.&#xa0;Neuroimmunol. 2000;110:177&#x2013;185. doi: 10.1016/s0165-5728(00)00343-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0165-5728(00)00343-x</ArticleId><ArticleId IdType="pubmed">11024548</ArticleId></ArticleIdList></Reference><Reference><Citation>Han K.H., Tangirala R.K., Green S.R., Quehenberger O. Chemokine receptor CCR2 expression and monocyte chemoattractant protein-1-mediated chemotaxis in human monocytes. A regulatory role for plasma LDL. Arterioscler. Thromb. Vasc. Biol. 1998;18:1983&#x2013;1991. doi: 10.1161/01.atv.18.12.1983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.atv.18.12.1983</ArticleId><ArticleId IdType="pubmed">9848893</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendelman H.E., Ding S., Gong N., Liu J., Ramirez S.H., Persidsky Y., Lee Mosley R., Wang T., Volsky D.J., Xiong H. Monocyte chemotactic protein-1 regulates voltage-gated K+ channels and macrophage transmigration. J.&#xa0;Neuroimmune Pharmacol. 2009;4:47&#x2013;59. doi: 10.1007/s11481-008-9135-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-008-9135-1</ArticleId><ArticleId IdType="pmc">PMC2657224</ArticleId><ArticleId IdType="pubmed">19034671</ArticleId></ArticleIdList></Reference><Reference><Citation>He M., Dong H., Huang Y., Lu S., Zhang S., Qian Y., Jin W. Astrocyte-derived CCL2 is associated with M1 activation and recruitment of cultured microglial cells. Cell. Physiol. Biochem. 2016;38:859&#x2013;870. doi: 10.1159/000443040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000443040</ArticleId><ArticleId IdType="pubmed">26910882</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr M.W., Roth S.J., Luther E., Rose S.S., Springer T.A. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc. Natl. Acad. Sci. U&#xa0;S&#xa0;A. 1994;91:3652&#x2013;3656. doi: 10.1073/pnas.91.9.3652.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.91.9.3652</ArticleId><ArticleId IdType="pmc">PMC43639</ArticleId><ArticleId IdType="pubmed">8170963</ArticleId></ArticleIdList></Reference><Reference><Citation>Frade J.M., Mellado M., del Real G., Gutierrez-Ramos J.C., Lind P., Martinez-A C. Characterization of the CCR2 chemokine receptor: functional CCR2 receptor expression in B cells. J.&#xa0;Immunol. 1997;159:5576&#x2013;5584.</Citation><ArticleIdList><ArticleId IdType="pubmed">9548499</ArticleId></ArticleIdList></Reference><Reference><Citation>Allavena P., Bianchi G., Zhou D., van Damme J., J&#xed;lek P., Sozzani S., Mantovani A. Induction of natural killer cell migration by monocyte chemotactic protein-1, -2 and -3. Eur. J. Immunol. 1994;24:3233&#x2013;3236. doi: 10.1002/eji.1830241249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.1830241249</ArticleId><ArticleId IdType="pubmed">7805752</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu P., Zhang J., Wang H., Wang G., Wang C.-Y., Zhang J. CCR2 dependent neutrophil activation and mobilization rely on TLR4-p38 axis during liver ischemia-reperfusion injury. Am. J. Transl. Res. 2017;9:2878&#x2013;2890.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5489888</ArticleId><ArticleId IdType="pubmed">28670376</ArticleId></ArticleIdList></Reference><Reference><Citation>Semple B.D., Kossmann T., Morganti-Kossmann M.C. Role of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/CXCR2 networks. J.&#xa0;Cereb. Blood Flow Metab. 2010;30:459&#x2013;473. doi: 10.1038/jcbfm.2009.240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jcbfm.2009.240</ArticleId><ArticleId IdType="pmc">PMC2949152</ArticleId><ArticleId IdType="pubmed">19904283</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez H.R.R., Escamilla-Oca&#xf1;as C.E.E., Camara-Lemarroy C.R.R., Gonz&#xe1;lez-Garza M.T.T., Moreno-Cuevas J., Garc&#xed;a Sarre&#xf3;n M.A.A. Increased cerebrospinal fluid levels of cytokines monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1&#x3b2; (MIP-1&#x3b2;) in patients with amyotrophic lateral sclerosis. Neurologia. 2020;35:165&#x2013;169. doi: 10.1016/j.nrleng.2017.07.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nrleng.2017.07.016</ArticleId><ArticleId IdType="pubmed">29029824</ArticleId></ArticleIdList></Reference><Reference><Citation>Henkel J.S., Beers D.R., Sikl&#xf3;s L., Appel S.H. The chemokine MCP-1 and the dendritic and myeloid cells it attracts are increased in the mSOD1 mouse model of ALS. Mol. Cell. Neurosci. 2006;31:427&#x2013;437. doi: 10.1016/j.mcn.2005.10.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2005.10.016</ArticleId><ArticleId IdType="pubmed">16337133</ArticleId></ArticleIdList></Reference><Reference><Citation>Dzenko K.A., Song L., Ge S., Kuziel W.A., Pachter J.S. CCR2 expression by brain microvascular endothelial cells is critical for macrophage transendothelial migration in response to CCL2. Microvasc. Res. 2005;70:53&#x2013;64. doi: 10.1016/j.mvr.2005.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mvr.2005.04.005</ArticleId><ArticleId IdType="pubmed">15927208</ArticleId></ArticleIdList></Reference><Reference><Citation>Chintawar S., Cayrol R., Antel J., Pandolfo M., Prat A. Blood-brain barrier promotes differentiation of human fetal neural precursor cells. Stem Cells. 2009;27:838&#x2013;846. doi: 10.1002/stem.25.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.25</ArticleId><ArticleId IdType="pubmed">19350685</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X.S., Zhang Z.G., Zhang R.L., Gregg S.R., Wang L., Yier T., Chopp M. Chemokine ligand 2 (CCL2) induces migration and differentiation of subventricular zone cells after stroke. J.&#xa0;Neurosci. Res. 2007;85:2120&#x2013;2125. doi: 10.1002/jnr.21359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.21359</ArticleId><ArticleId IdType="pubmed">17510981</ArticleId></ArticleIdList></Reference><Reference><Citation>Locatelli D., Terao M., Fratelli M., Zanetti A., Kurosaki M., Lupi M., Barzago M.M., Uggetti A., Capra S., D'Errico P., et al. Human axonal survival of motor neuron (a-SMN) protein stimulates axon growth, cell motility, C-C motif ligand 2 (CCL2), and insulin-like growth factor-1 (IGF1) production. J.&#xa0;Biol. Chem. 2012;287:25782&#x2013;25794. doi: 10.1074/jbc.m112.362830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.m112.362830</ArticleId><ArticleId IdType="pmc">PMC3406665</ArticleId><ArticleId IdType="pubmed">22669976</ArticleId></ArticleIdList></Reference><Reference><Citation>Papa S., Vismara I., Mariani A., Barilani M., Rimondo S., De Paola M., Panini N., Erba E., Mauri E., Rossi F., et al. Mesenchymal stem cells encapsulated into biomimetic hydrogel scaffold gradually release CCL2 chemokine in&#xa0;situ preserving cytoarchitecture and promoting functional recovery in spinal cord injury. J.&#xa0;Control. Release. 2018;278:49&#x2013;56. doi: 10.1016/j.jconrel.2018.03.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jconrel.2018.03.034</ArticleId><ArticleId IdType="pubmed">29621597</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang F., Wang Y., Han G.H., Ding X., Wei S., Gao G., Huang K. Role of macrophages in peripheral nerve injury and repair. Neural Regen. Res. 2019;14:1335&#x2013;1342. doi: 10.4103/1673-5374.253510.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.253510</ArticleId><ArticleId IdType="pmc">PMC6524518</ArticleId><ArticleId IdType="pubmed">30964051</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen P., Piao X., Bonaldo P. Role of macrophages in Wallerian degeneration and axonal regeneration after peripheral nerve injury. Acta Neuropathol. 2015;130:605&#x2013;618. doi: 10.1007/s00401-015-1482-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1482-4</ArticleId><ArticleId IdType="pubmed">26419777</ArticleId></ArticleIdList></Reference><Reference><Citation>Zigmond R.E., Echevarria F.D. Macrophage biology in the peripheral nervous system after injury. Prog. Neurobiol. 2019;173:102&#x2013;121. doi: 10.1016/j.pneurobio.2018.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2018.12.001</ArticleId><ArticleId IdType="pmc">PMC6340791</ArticleId><ArticleId IdType="pubmed">30579784</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez C.O., McHale M.J., Wells J.T., Ochoa O., Michalek J.E., McManus L.M., Shireman P.K. Regulation of skeletal muscle regeneration by CCR2-activating chemokines is directly related to macrophage recruitment. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2010;299:R832&#x2013;R842. doi: 10.1152/ajpregu.00797.2009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpregu.00797.2009</ArticleId><ArticleId IdType="pmc">PMC2944434</ArticleId><ArticleId IdType="pubmed">20631294</ArticleId></ArticleIdList></Reference><Reference><Citation>Dort J., Fabre P., Molina T., Dumont N.A. Macrophages are key regulators of stem cells during skeletal muscle regeneration and diseases. Stem Cells Int. 2019;2019:4761427. doi: 10.1155/2019/4761427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/4761427</ArticleId><ArticleId IdType="pmc">PMC6664695</ArticleId><ArticleId IdType="pubmed">31396285</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Xiao Z., Qu C., Cui W., Wang X., Du J. CD8 T&#xa0;cells are involved in skeletal muscle regeneration through facilitating MCP-1 secretion and Gr1 high macrophage infiltration. J.&#xa0;Immunol. 2014;193:5149&#x2013;5160. doi: 10.4049/jimmunol.1303486.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1303486</ArticleId><ArticleId IdType="pubmed">25339660</ArticleId></ArticleIdList></Reference><Reference><Citation>Deyhle M.R., Hyldahl R.D. The role of T lymphocytes in skeletal muscle repair from traumatic and contraction-induced injury. Front. Physiol. 2018;9:768. doi: 10.3389/fphys.2018.00768.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2018.00768</ArticleId><ArticleId IdType="pmc">PMC6019499</ArticleId><ArticleId IdType="pubmed">29973887</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang W., Hu P. Skeletal muscle regeneration is modulated by inflammation. J.&#xa0;Orthop. Transl. 2018;13:25&#x2013;32. doi: 10.1016/j.jot.2018.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jot.2018.01.002</ArticleId><ArticleId IdType="pmc">PMC5892385</ArticleId><ArticleId IdType="pubmed">29662788</ArticleId></ArticleIdList></Reference><Reference><Citation>Kano O., Beers D.R., Henkel J.S., Appel S.H. Peripheral nerve inflammation in ALS mice: cause or consequence. Neurology. 2012;78:833&#x2013;835. doi: 10.1212/wnl.0b013e318249f776.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.0b013e318249f776</ArticleId><ArticleId IdType="pmc">PMC3304948</ArticleId><ArticleId IdType="pubmed">22377817</ArticleId></ArticleIdList></Reference><Reference><Citation>Trias E., King P.H., Si Y., Kwon Y., Varela V., Ibarburu S., Kovacs M., Moura I.C., Beckman J.S., Hermine O., Barbeito L. Mast cells and neutrophils mediate peripheral motor pathway degeneration in ALS. JCI Insight. 2018;3:e123249. doi: 10.1172/jci.insight.123249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.123249</ArticleId><ArticleId IdType="pmc">PMC6237484</ArticleId><ArticleId IdType="pubmed">30282815</ArticleId></ArticleIdList></Reference><Reference><Citation>Benkhelifa-Ziyyat S., Besse A., Roda M., Duque S., Astord S., Carcenac R., Marais T., Barkats M. Intramuscular scAAV9-SMN injection mediates widespread gene delivery to the spinal cord and decreases disease severity in SMA mice. Mol. Ther. 2013;21:282&#x2013;290. doi: 10.1038/mt.2012.261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mt.2012.261</ArticleId><ArticleId IdType="pmc">PMC3594018</ArticleId><ArticleId IdType="pubmed">23295949</ArticleId></ArticleIdList></Reference><Reference><Citation>Hegedus J., Putman C.T., Gordon T. Time course of preferential motor unit loss in the SOD1G93A mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 2007;28:154&#x2013;164. doi: 10.1016/j.nbd.2007.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2007.07.003</ArticleId><ArticleId IdType="pubmed">17766128</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark J.A., Southam K.A., Blizzard C.A., King A.E., Dickson T.C. Axonal degeneration, distal collateral branching and neuromuscular junction architecture alterations occur prior to symptom onset in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. J.&#xa0;Chem. Neuroanat. 2016;76:35&#x2013;47. doi: 10.1016/j.jchemneu.2016.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchemneu.2016.03.003</ArticleId><ArticleId IdType="pubmed">27038603</ArticleId></ArticleIdList></Reference><Reference><Citation>Loeffler J.P., Picchiarelli G., Dupuis L., Gonzalez De Aguilar J.L. The role of skeletal muscle in amyotrophic lateral sclerosis. Brain Pathol. 2016;26:227&#x2013;236. doi: 10.1111/bpa.12350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12350</ArticleId><ArticleId IdType="pmc">PMC8029271</ArticleId><ArticleId IdType="pubmed">26780251</ArticleId></ArticleIdList></Reference><Reference><Citation>Campanari M.-L., Garc&#xed;a-Ayll&#xf3;n M.-S., Ciura S., S&#xe1;ez-Valero J., Kabashi E. Neuromuscular junction impairment in amyotrophic lateral sclerosis: reassessing the role of acetylcholinesterase. Front. Mol. Neurosci. 2016;9:160. doi: 10.3389/fnmol.2016.00160.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2016.00160</ArticleId><ArticleId IdType="pmc">PMC5187284</ArticleId><ArticleId IdType="pubmed">28082868</ArticleId></ArticleIdList></Reference><Reference><Citation>Wier C.G., Crum A.E., Reynolds A.B., Iyer C.C., Chugh D., Palettas M.S., Heilman P.L., Kline D.M., Arnold W.D., Kolb S.J. Muscle contractility dysfunction precedes loss of motor unit connectivity in SOD1(G93A) mice. Muscle Nerve. 2019;59:254&#x2013;262. doi: 10.1002/mus.26365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26365</ArticleId><ArticleId IdType="pmc">PMC6340745</ArticleId><ArticleId IdType="pubmed">30370671</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruijn L.I., Becher M.W.W., Lee M.K., Anderson K.L., Jenkins N.A., Copeland N.G., Sisodia S., Rothstein J.D., Borchelt D.R., Price D.L., Cleveland D.W. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron. 1997;18:327&#x2013;338. doi: 10.1016/s0896-6273(00)80272-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0896-6273(00)80272-x</ArticleId><ArticleId IdType="pubmed">9052802</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrowolny G., Lepore E., Martini M., Barberi L., Nunn A., Scicchitano B.M., Musaro A. Metabolic changes associated with muscle expression of SOD1G93A. Front. Physiol. 2018;9:831. doi: 10.3389/fphys.2018.00831.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2018.00831</ArticleId><ArticleId IdType="pmc">PMC6048270</ArticleId><ArticleId IdType="pubmed">30042688</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrowolny G., Aucello M., Musar&#xf2; A. Muscle atrophy induced by SOD1G93A expression does not involve the activation of caspase in the absence of denervation. Skelet. Muscle. 2011;1:3. doi: 10.1186/2044-5040-1-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2044-5040-1-3</ArticleId><ArticleId IdType="pmc">PMC3143901</ArticleId><ArticleId IdType="pubmed">21798081</ArticleId></ArticleIdList></Reference><Reference><Citation>Frey D., Schneider C., Xu L., Borg J., Spooren W., Caroni P. Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J.&#xa0;Neurosci. 2000;20:2534&#x2013;2542. doi: 10.1523/jneurosci.20-07-02534.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/jneurosci.20-07-02534.2000</ArticleId><ArticleId IdType="pmc">PMC6772256</ArticleId><ArticleId IdType="pubmed">10729333</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison J.M., Rafuse V.F. Muscle fiber-type specific terminal Schwann cell pathology leads to sprouting deficits following partial denervation in SOD1G93A mice. Neurobiol. Dis. 2020;145:105052. doi: 10.1016/j.nbd.2020.105052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.105052</ArticleId><ArticleId IdType="pubmed">32827689</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu H., Huang D., Saederup N., Charo I.F., Ransohoff R.M., Zhou L. Macrophages recruited via CCR2 produce insulin-like growth factor-1 to repair acute skeletal muscle injury. FASEB J. 2011;25:358&#x2013;369. doi: 10.1096/fj.10-171579.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.10-171579</ArticleId><ArticleId IdType="pmc">PMC3005436</ArticleId><ArticleId IdType="pubmed">20889618</ArticleId></ArticleIdList></Reference><Reference><Citation>Chazaud B. Inflammation and skeletal muscle regeneration: leave it to the macrophages. Trends Immunol. 2020;41:481&#x2013;492. doi: 10.1016/j.it.2020.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2020.04.006</ArticleId><ArticleId IdType="pubmed">32362490</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H.A., Lee J.D., Lee K.M., Woodruff T.M., Noakes P.G. Complement C5a-C5aR1 signalling drives skeletal muscle macrophage recruitment in the hSOD1G93A mouse model of amyotrophic lateral sclerosis. Skelet. Muscle. 2017;7:10. doi: 10.1186/s13395-017-0128-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13395-017-0128-8</ArticleId><ArticleId IdType="pmc">PMC5455206</ArticleId><ArticleId IdType="pubmed">28571586</ArticleId></ArticleIdList></Reference><Reference><Citation>Luther S.A., Cyster J.G. Chemokines as regulators of T&#xa0;cell differentiation. Nat. Immunol. 2001;2:102&#x2013;107. doi: 10.1038/84205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/84205</ArticleId><ArticleId IdType="pubmed">11175801</ArticleId></ArticleIdList></Reference><Reference><Citation>Tidball J.G. Regulation of muscle growth and regeneration by the immune system. Nat. Rev. Immunol. 2017;17:165&#x2013;178. doi: 10.1038/nri.2016.150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2016.150</ArticleId><ArticleId IdType="pmc">PMC5452982</ArticleId><ArticleId IdType="pubmed">28163303</ArticleId></ArticleIdList></Reference><Reference><Citation>Oishi Y., Manabe I. Macrophages in inflammation, repair and regeneration. Int. Immunol. 2018;30:511&#x2013;528. doi: 10.1093/intimm/dxy054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/dxy054</ArticleId><ArticleId IdType="pubmed">30165385</ArticleId></ArticleIdList></Reference><Reference><Citation>Castiglioni A., Corna G., Rigamonti E., Basso V., Vezzoli M., Monno A., Almada A.E., Mondino A., Wagers A.J., Manfredi A.A., Rovere-Querini P. FOXP3+ T&#xa0;cells recruited to sites of sterile skeletal muscle injury regulate the fate of satellite cells and Guide effective tissue regeneration. PLoS One. 2015;10:e0128094. doi: 10.1371/journal.pone.0128094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0128094</ArticleId><ArticleId IdType="pmc">PMC4454513</ArticleId><ArticleId IdType="pubmed">26039259</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiaffino S., Pereira M.G., Ciciliot S., Rovere-Querini P. Regulatory T&#xa0;cells and skeletal muscle regeneration. FEBS J. 2017;284:517&#x2013;524. doi: 10.1111/febs.13827.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.13827</ArticleId><ArticleId IdType="pubmed">27479876</ArticleId></ArticleIdList></Reference><Reference><Citation>Teixeira C.F.P., Zamun&#xe9;r S.R., Zuliani J.P., Fernandes C.M., Cruz-Hofling M.A., Fernandes I., Chaves F., Gutierrez J.M. Neutrophils do not contribute to local tissue damage, but play a key role in skeletal muscle regeneration, in mice injected with Bothrops asper snake venom. Muscle Nerve. 2003;28:449&#x2013;459. doi: 10.1002/mus.10453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.10453</ArticleId><ArticleId IdType="pubmed">14506717</ArticleId></ArticleIdList></Reference><Reference><Citation>Tidball J.G. Inflammatory cell response to acute muscle injury. Med. Sci. Sports Exerc. 1995;27:1022&#x2013;1032. doi: 10.1249/00005768-199507000-00011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1249/00005768-199507000-00011</ArticleId><ArticleId IdType="pubmed">7564969</ArticleId></ArticleIdList></Reference><Reference><Citation>Villalta S.A., Nguyen H.X., Deng B., Gotoh T., Tidball J.G. Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy. Hum. Mol. Genet. 2009;18:482&#x2013;496. doi: 10.1093/hmg/ddn376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddn376</ArticleId><ArticleId IdType="pmc">PMC2638796</ArticleId><ArticleId IdType="pubmed">18996917</ArticleId></ArticleIdList></Reference><Reference><Citation>Tonkin J., Temmerman L., Sampson R.D., Gallego-Colon E., Barberi L., Bilbao D., Schneider M.D., Musaro A., Rosenthal N. Monocyte/Macrophage-derived IGF-1 orchestrates murine skeletal muscle regeneration and modulates autocrine polarization. Mol. Ther. 2015;23:1189&#x2013;1200. doi: 10.1038/mt.2015.66.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mt.2015.66</ArticleId><ArticleId IdType="pmc">PMC4817788</ArticleId><ArticleId IdType="pubmed">25896247</ArticleId></ArticleIdList></Reference><Reference><Citation>Tonkin J., Villarroya F., Puri P.L., Vinciguerra M. SIRT1 signaling as potential modulator of skeletal muscle diseases. Curr. Opin. Pharmacol. 2012;12:372&#x2013;376. doi: 10.1016/j.coph.2012.02.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coph.2012.02.010</ArticleId><ArticleId IdType="pubmed">22401932</ArticleId></ArticleIdList></Reference><Reference><Citation>Schug T.T., Xu Q., Gao H., Peres-da-Silva A., Draper D.W., Fessler M.B., Purushotham A., Li X. Myeloid deletion of SIRT1 induces inflammatory signaling in response to environmental stress. Mol. Cell. Biol. 2010;30:4712&#x2013;4721. doi: 10.1128/mcb.00657-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mcb.00657-10</ArticleId><ArticleId IdType="pmc">PMC2950528</ArticleId><ArticleId IdType="pubmed">20647536</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold L., Henry A., Poron F., Baba-Amer Y., van Rooijen N., Plonquet A., Gherardi R.K., Chazaud B. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J.&#xa0;Exp. Med. 2007;204:1057&#x2013;1069. doi: 10.1084/jem.20070075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20070075</ArticleId><ArticleId IdType="pmc">PMC2118577</ArticleId><ArticleId IdType="pubmed">17485518</ArticleId></ArticleIdList></Reference><Reference><Citation>Kharraz Y., Guerra J., Mann C.J., Serrano A.L., Mu&#xf1;oz-C&#xe1;noves P. Macrophage plasticity and the role of inflammation in skeletal muscle repair. Mediators Inflamm. 2013;2013:4914957. doi: 10.1155/2013/491497.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/491497</ArticleId><ArticleId IdType="pmc">PMC3572642</ArticleId><ArticleId IdType="pubmed">23509419</ArticleId></ArticleIdList></Reference><Reference><Citation>Saclier M., Yacoub-Youssef H., Mackey A.L., Arnold L., Ardjoune H., Magnan M., Sailhan F., Chelly J., Pavlath G.K., Mounier R., et al. Differentially activated macrophages orchestrate myogenic precursor cell fate during human skeletal muscle regeneration. Stem Cells. 2013;31:384&#x2013;396. doi: 10.1002/stem.1288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.1288</ArticleId><ArticleId IdType="pubmed">23169615</ArticleId></ArticleIdList></Reference><Reference><Citation>Patsalos A., Pap A., Varga T., Trencsenyi G., Contreras G.A., Garai I., Papp Z., Dezso B., Pintye E., Nagy L. In situ macrophage phenotypic transition is affected by altered cellular composition prior to acute sterile muscle injury. J.&#xa0;Physiol. 2017;595:5815&#x2013;5842. doi: 10.1113/jp274361.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jp274361</ArticleId><ArticleId IdType="pmc">PMC5577539</ArticleId><ArticleId IdType="pubmed">28714082</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauro A. Satellite cell of skeletal muscle fibers. J.&#xa0;Biophys. Biochem. Cytol. 1961;9:493&#x2013;495. doi: 10.1083/jcb.9.2.493.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.9.2.493</ArticleId><ArticleId IdType="pmc">PMC2225012</ArticleId><ArticleId IdType="pubmed">13768451</ArticleId></ArticleIdList></Reference><Reference><Citation>Cornelison D.D., Wold B.J. Single-cell analysis of regulatory gene expression in quiescent and activated mouse skeletal muscle satellite cells. Dev. Biol. 1997;191:270&#x2013;283. doi: 10.1006/dbio.1997.8721.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/dbio.1997.8721</ArticleId><ArticleId IdType="pubmed">9398440</ArticleId></ArticleIdList></Reference><Reference><Citation>Relaix F., Zammit P.S. Satellite cells are essential for skeletal muscle regeneration: the cell on the edge returns centre stage. Development. 2012;139:2845&#x2013;2856. doi: 10.1242/dev.069088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.069088</ArticleId><ArticleId IdType="pubmed">22833472</ArticleId></ArticleIdList></Reference><Reference><Citation>Forcina L., Miano C., Pelosi L., Musar&#xf2; A. An overview about the biology of skeletal muscle satellite cells. Curr. Genomics. 2019;20:24&#x2013;37. doi: 10.2174/1389202920666190116094736.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1389202920666190116094736</ArticleId><ArticleId IdType="pmc">PMC6446479</ArticleId><ArticleId IdType="pubmed">31015789</ArticleId></ArticleIdList></Reference><Reference><Citation>Folker E.S., Baylies M.K. Nuclear positioning in muscle development and disease. Front. Physiol. 2013;4:363. doi: 10.3389/fphys.2013.00363.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2013.00363</ArticleId><ArticleId IdType="pmc">PMC3859928</ArticleId><ArticleId IdType="pubmed">24376424</ArticleId></ArticleIdList></Reference><Reference><Citation>Hegedus J., Putman C.T., Tyreman N., Gordon T. Preferential motor unit loss in the SOD1 G93A transgenic mouse model of amyotrophic lateral sclerosis. J.&#xa0;Physiol. 2008;586:3337&#x2013;3351. doi: 10.1113/jphysiol.2007.149286.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2007.149286</ArticleId><ArticleId IdType="pmc">PMC2538809</ArticleId><ArticleId IdType="pubmed">18467368</ArticleId></ArticleIdList></Reference><Reference><Citation>Palamiuc L., Schlagowski A., Ngo S.T., Vernay A., Dirrig-Grosch S., Henriques A., Boutillier A., Zoll J., Echaniz-Laguna A., Loeffler J., Rene F. A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis. EMBO Mol. Med. 2015;7:526&#x2013;546. doi: 10.15252/emmm.201404433.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201404433</ArticleId><ArticleId IdType="pmc">PMC4492815</ArticleId><ArticleId IdType="pubmed">25820275</ArticleId></ArticleIdList></Reference><Reference><Citation>Meeker R.B., Williams K.S. The p75 neurotrophin receptor: at the crossroad of neural repair and death. Neural Regen. Res. 2015;10:721&#x2013;725. doi: 10.4103/1673-5374.156967.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.156967</ArticleId><ArticleId IdType="pmc">PMC4468762</ArticleId><ArticleId IdType="pubmed">26109945</ArticleId></ArticleIdList></Reference><Reference><Citation>Song X.-Y., Zhou F.H.-H., Zhong J.-H., Wu L.L.Y., Zhou X.-F. Knockout of p75(NTR) impairs re-myelination of injured sciatic nerve in mice. J.&#xa0;Neurochem. 2006;96:833&#x2013;842. doi: 10.1111/j.1471-4159.2005.03564.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2005.03564.x</ArticleId><ArticleId IdType="pubmed">16336221</ArticleId></ArticleIdList></Reference><Reference><Citation>Butovsky O., Siddiqui S., Gabriely G., Lanser A.J., Dake B., Murugaiyan G., Doykan C.E., Wu P.M., Gali R.R., Iyer L.K., et al. Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS. J.&#xa0;Clin. Invest. 2012;122:3063&#x2013;3087. doi: 10.1172/jci62636.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci62636</ArticleId><ArticleId IdType="pmc">PMC3428086</ArticleId><ArticleId IdType="pubmed">22863620</ArticleId></ArticleIdList></Reference><Reference><Citation>Sargsyan S.A., Blackburn D.J., Barber S.C., Monk P.N., Shaw P.J. Mutant SOD1 G93A microglia have an inflammatory phenotype and elevated production of MCP-1. Neuroreport. 2009;20:1450&#x2013;1455. doi: 10.1097/wnr.0b013e328331e8fa.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/wnr.0b013e328331e8fa</ArticleId><ArticleId IdType="pmc">PMC2889291</ArticleId><ArticleId IdType="pubmed">19752764</ArticleId></ArticleIdList></Reference><Reference><Citation>Henkel J.S., Beers D.R., Zhao W., Appel S.H. Microglia in ALS: the good, the bad, and the resting. J.&#xa0;Neuroimmune Pharmacol. 2009;4:389&#x2013;398. doi: 10.1007/s11481-009-9171-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-009-9171-5</ArticleId><ArticleId IdType="pubmed">19731042</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers D.R., Henkel J.S., Zhao W., Wang J., Huang A., Wen S., Liao B., Appel S.H. Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis. Brain. 2011;134:1293&#x2013;1314. doi: 10.1093/brain/awr074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr074</ArticleId><ArticleId IdType="pmc">PMC3097891</ArticleId><ArticleId IdType="pubmed">21596768</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney M.E. The use of transgenic mouse models of amyotrophic lateral sclerosis in preclinical drug studies. J.&#xa0;Neurol. Sci. 1997;152:s67&#x2013;s73. doi: 10.1016/s0022-510x(97)00247-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-510x(97)00247-5</ArticleId><ArticleId IdType="pubmed">9419057</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.X., et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science. 1994;264:1772&#x2013;1775. doi: 10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Bendotti C., Carr&#xec; M.T. Lessons from models of SOD1-linked familial ALS. Trends Mol. Med. 2004;10:393&#x2013;400. doi: 10.1016/j.molmed.2004.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2004.06.009</ArticleId><ArticleId IdType="pubmed">15310460</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xe4;fer S., Hermans E. Reassessment of motor-behavioural test analyses enables the detection of early disease-onset in a transgenic mouse model of amyotrophic lateral sclerosis. Behav. Brain Res. 2011;225:7&#x2013;14. doi: 10.1016/j.bbr.2011.06.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbr.2011.06.019</ArticleId><ArticleId IdType="pubmed">21723884</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardo G., Trolese M.C., Verderio M., Mariani A., de Paola M., Riva N., Dina G., Panini N., Erba E., Quattrini A., Bendotti C. Counteracting roles of MHCI and CD8+ T&#xa0;cells in the peripheral and central nervous system of ALS SOD1G93A mice. Mol. Neurodegener. 2018;13:42. doi: 10.1186/s13024-018-0271-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-018-0271-7</ArticleId><ArticleId IdType="pmc">PMC6085701</ArticleId><ArticleId IdType="pubmed">30092791</ArticleId></ArticleIdList></Reference><Reference><Citation>Deshmane S.L., Kremlev S., Amini S., Sawaya B.E. Monocyte chemoattractant protein-1 (MCP-1): an overview. J.&#xa0;Interf. Cytokine Res. 2009;29:313&#x2013;326. doi: 10.1089/jir.2008.0027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jir.2008.0027</ArticleId><ArticleId IdType="pmc">PMC2755091</ArticleId><ArticleId IdType="pubmed">19441883</ArticleId></ArticleIdList></Reference><Reference><Citation>Conductier G., Blondeau N., Guyon A., Nahon J.-L., Rov&#xe8;re C. The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases. J.&#xa0;Neuroimmunol. 2010;224:93&#x2013;100. doi: 10.1016/j.jneuroim.2010.05.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2010.05.010</ArticleId><ArticleId IdType="pubmed">20681057</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawyer A.J., Tian W., Saucier-Sawyer J.K., Rizk P.J., Saltzman W.M., Bellamkonda R.V., Kyriakides T.R. The effect of inflammatory cell-derived MCP-1 loss on neuronal survival during chronic neuroinflammation. Biomaterials. 2014;35:6698&#x2013;6706. doi: 10.1016/j.biomaterials.2014.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biomaterials.2014.05.008</ArticleId><ArticleId IdType="pmc">PMC4128094</ArticleId><ArticleId IdType="pubmed">24881026</ArticleId></ArticleIdList></Reference><Reference><Citation>Semple B.D., Frugier T., Morganti-Kossmann M.C. CCL2 modulates cytokine production in cultured mouse astrocytes. J.&#xa0;Neuroinflammation. 2010;7:67. doi: 10.1186/1742-2094-7-67.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-7-67</ArticleId><ArticleId IdType="pmc">PMC2964657</ArticleId><ArticleId IdType="pubmed">20942978</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilms H., Sievers J., Dengler R., Bufler J., Deuschl G., Lucius R. Intrathecal synthesis of monocyte chemoattractant protein-1 (MCP-1) in amyotrophic lateral sclerosis: further evidence for microglial activation in neurodegeneration. J.&#xa0;Neuroimmunol. 2003;144:139&#x2013;142. doi: 10.1016/j.jneuroim.2003.08.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2003.08.042</ArticleId><ArticleId IdType="pubmed">14597108</ArticleId></ArticleIdList></Reference><Reference><Citation>Baron P., Bussini S., Cardin V., Corbo M., Conti G., Galimberti D., Scarpini E., Bresolin N., Wharton S.B., Shaw P.J., Silani V. Production of monocyte chemoattractant protein-1 in amyotrophic lateral sclerosis. Muscle Nerve. 2005;32:541&#x2013;544. doi: 10.1002/mus.20376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.20376</ArticleId><ArticleId IdType="pubmed">15962273</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagata T., Nagano I., Shiote M., Narai H., Murakami T., Hayashi T., Shoji M., Abe K. Elevation of MCP-1 and MCP-1/VEGF ratio in cerebrospinal fluid of amyotrophic lateral sclerosis patients. Neurol. Res. 2007;29:772&#x2013;776. doi: 10.1179/016164107x229795.</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/016164107x229795</ArticleId><ArticleId IdType="pubmed">17672928</ArticleId></ArticleIdList></Reference><Reference><Citation>Tofaris G.K., Patterson P.H., Jessen K.R., Mirsky R. Denervated Schwann cells attract macrophages by secretion of leukemia inhibitory factor (LIF) and monocyte chemoattractant protein-1 in a process regulated by interleukin-6 and LIF. J.&#xa0;Neurosci. 2002;22:6696&#x2013;6703. doi: 10.1523/jneurosci.22-15-06696.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/jneurosci.22-15-06696.2002</ArticleId><ArticleId IdType="pmc">PMC6758146</ArticleId><ArticleId IdType="pubmed">12151548</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon M.J., Shin H.Y., Cui Y., Kim H., Thi A.H.L., Choi J.Y., Kim E.Y., Hwang D.H., Kim B.G. CCL2 mediates neuron-macrophage interactions to drive proregenerative macrophage activation following preconditioning injury. J.&#xa0;Neurosci. 2015;35:15934&#x2013;15947. doi: 10.1523/jneurosci.1924-15.2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/jneurosci.1924-15.2015</ArticleId><ArticleId IdType="pmc">PMC6605453</ArticleId><ArticleId IdType="pubmed">26631474</ArticleId></ArticleIdList></Reference><Reference><Citation>Stratton J.A., Eaton S., Rosin N.L., Jawad S., Holmes A., Yoon G., Midha R., Biernaskie J. Macrophages and associated ligands in the aged injured nerve: a defective dynamic that contributes to reduced axonal regrowth. Front. Aging Neurosci. 2020;12:174. doi: 10.3389/fnagi.2020.00174.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2020.00174</ArticleId><ArticleId IdType="pmc">PMC7304384</ArticleId><ArticleId IdType="pubmed">32595489</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiraishi W., Yamasaki R., Hashimoto Y., Ko S., Kobayakawa Y., Isobe N., Matsushita T., Kira J.I. Clearance of peripheral nerve misfolded mutant protein by infiltrated macrophages correlates with motor neuron disease progression. Sci. Rep. 2021;11:16438. doi: 10.1038/s41598-021-96064-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-96064-6</ArticleId><ArticleId IdType="pmc">PMC8360983</ArticleId><ArticleId IdType="pubmed">34385589</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu H., Huang D., Ransohoff R.M., Zhou L. Acute skeletal muscle injury: CCL2 expression by both monocytes and injured muscle is required for repair. FASEB J. 2011;25:3344&#x2013;3355. doi: 10.1096/fj.10-178939.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.10-178939</ArticleId><ArticleId IdType="pmc">PMC3177578</ArticleId><ArticleId IdType="pubmed">21697550</ArticleId></ArticleIdList></Reference><Reference><Citation>Lincecum J.M., Vieira F.G., Wang M.Z., Thompson K., De Zutter G.S., Kidd J., Moreno A., Sanchez R., Carrion I.J., Levine B.A., et al. From transcriptome analysis to therapeutic anti-CD40L treatment in the SOD1 model of amyotrophic lateral sclerosis. Nat. Genet. 2010;42:392&#x2013;399. doi: 10.1038/ng.557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.557</ArticleId><ArticleId IdType="pubmed">20348957</ArticleId></ArticleIdList></Reference><Reference><Citation>Graber D.J., Hickey W.F., Harris B.T. Progressive changes in microglia and macrophages in spinal cord and peripheral nerve in the transgenic rat model of amyotrophic lateral sclerosis. J.&#xa0;Neuroinflammation. 2010;7:8. doi: 10.1186/1742-2094-7-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-7-8</ArticleId><ArticleId IdType="pmc">PMC2825214</ArticleId><ArticleId IdType="pubmed">20109233</ArticleId></ArticleIdList></Reference><Reference><Citation>Scala P., Rehak L., Giudice V., Ciaglia E., Puca A.A., Selleri C., Della Porta G., Maffulli N. Stem cell and macrophage roles in skeletal muscle regenerative medicine. Int. J. Mol. Sci. 2021;22:10867. doi: 10.3390/ijms221910867.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms221910867</ArticleId><ArticleId IdType="pmc">PMC8509639</ArticleId><ArticleId IdType="pubmed">34639203</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziemkiewicz N., Hilliard G., Pullen N.A., Garg K. The role of innate and adaptive immune cells in skeletal muscle regeneration. Int. J. Mol. Sci. 2021;22:3265. doi: 10.3390/ijms22063265.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22063265</ArticleId><ArticleId IdType="pmc">PMC8005179</ArticleId><ArticleId IdType="pubmed">33806895</ArticleId></ArticleIdList></Reference><Reference><Citation>Howard E.E., Pasiakos S.M., Blesso C.N., Fussell M.A., Rodriguez N.R. Divergent roles of inflammation in skeletal muscle recovery from injury. Front. Physiol. 2020;11:87. doi: 10.3389/fphys.2020.00087.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2020.00087</ArticleId><ArticleId IdType="pmc">PMC7031348</ArticleId><ArticleId IdType="pubmed">32116792</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunis G., Baruch K., Miller O., Schwartz M. Immunization with a myelin-derived antigen activates the brain&#x2019;s choroid plexus for recruitment of immunoregulatory cells to the CNS and attenuates disease progression in a mouse model of ALS. J.&#xa0;Neurosci. 2015;35:6381&#x2013;6393. doi: 10.1523/jneurosci.3644-14.2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/jneurosci.3644-14.2015</ArticleId><ArticleId IdType="pmc">PMC6605216</ArticleId><ArticleId IdType="pubmed">25904790</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasco C., Canazza A., Rizzo A., Mossa A., Corsini E., Silvani A., Fariselli L., Salmaggi A., Ciusani E. Circulating T regulatory cells migration and phenotype in glioblastoma patients: an in&#xa0;vitro study. J.&#xa0;Neurooncol. 2013;115:353&#x2013;363. doi: 10.1007/s11060-013-1236-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11060-013-1236-x</ArticleId><ArticleId IdType="pubmed">24005771</ArticleId></ArticleIdList></Reference><Reference><Citation>Burzyn D., Kuswanto W., Kolodin D., Shadrach J.L., Cerletti M., Jang Y., Sefik E., Tan T.G., Wagers A.J., Benoist C., Mathis D. A special population of regulatory T&#xa0;cells potentiates muscle repair. Cell. 2013;155:1282&#x2013;1295. doi: 10.1016/j.cell.2013.10.054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.10.054</ArticleId><ArticleId IdType="pmc">PMC3894749</ArticleId><ArticleId IdType="pubmed">24315098</ArticleId></ArticleIdList></Reference><Reference><Citation>Villalta S.A., Rosenthal W., Martinez L., Kaur A., Sparwasser T., Tidball J.G., Margeta M., Spencer M.J., Bluestone J.A. Regulatory T&#xa0;cells suppress muscle inflammation and injury in muscular dystrophy. Sci. Transl. Med. 2014;6:258ra142. doi: 10.1126/scitranslmed.3009925.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3009925</ArticleId><ArticleId IdType="pmc">PMC4889432</ArticleId><ArticleId IdType="pubmed">25320234</ArticleId></ArticleIdList></Reference><Reference><Citation>Arecco N., Clarke C.J., Jones F.K., Simpson D.M., Mason D., Beynon R.J., Pisconti A. Elastase levels and activity are increased in dystrophic muscle and impair myoblast cell survival, proliferation and differentiation. Sci. Rep. 2016;6:24708. doi: 10.1038/srep24708.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep24708</ArticleId><ArticleId IdType="pmc">PMC4886533</ArticleId><ArticleId IdType="pubmed">27241590</ArticleId></ArticleIdList></Reference><Reference><Citation>Tidball J.G., Dorshkind K., Wehling-Henricks M. Shared signaling systems in myeloid cell-mediated muscle regeneration. Development. 2014;141:1184&#x2013;1196. doi: 10.1242/dev.098285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.098285</ArticleId><ArticleId IdType="pmc">PMC3943178</ArticleId><ArticleId IdType="pubmed">24595286</ArticleId></ArticleIdList></Reference><Reference><Citation>White P., Liebhaber S.A., Cooke N.E. 129X1/SvJ mouse strain has a novel defect in inflammatory cell recruitment. J.&#xa0;Immunol. 2002;168:869&#x2013;874. doi: 10.4049/jimmunol.168.2.869.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.168.2.869</ArticleId><ArticleId IdType="pubmed">11777984</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoover-Plow J.L., Gong Y., Shchurin A., Busuttil S.J., Schneeman T.A., Hart E. Strain and model dependent differences in inflammatory cell recruitment in mice. Inflamm. Res. 2008;57:457&#x2013;463. doi: 10.1007/s00011-008-7062-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-008-7062-5</ArticleId><ArticleId IdType="pmc">PMC3031869</ArticleId><ArticleId IdType="pubmed">18827970</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzo G., Di Maggio R., Benedetti A., Morroni J., Bouche M., Lozanoska-Ochser B. Splenic Ly6Chi monocytes are critical players in dystrophic muscle injury and repair. JCI Insight. 2020;5:1184&#x2013;1196. doi: 10.1172/jci.insight.130807.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.130807</ArticleId><ArticleId IdType="pmc">PMC7098719</ArticleId><ArticleId IdType="pubmed">31874104</ArticleId></ArticleIdList></Reference><Reference><Citation>Niemi J.P., DeFrancesco-Lisowitz A., Cregg J.M., Howarth M., Zigmond R.E. Overexpression of the monocyte chemokine CCL2 in dorsal root ganglion neurons causes a conditioning-like increase in neurite outgrowth and does so via a STAT3 dependent mechanism. Exp. Neurol. 2016;275:25&#x2013;37. doi: 10.1016/j.expneurol.2015.09.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2015.09.018</ArticleId><ArticleId IdType="pmc">PMC4688065</ArticleId><ArticleId IdType="pubmed">26431741</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiot A., Za&#xef;di S., Iltis C., Ribon M., Berriat F., Schiaffino L., Jolly A., de la Grange P., Mallat M., Bohl D., et al. Modifying macrophages at the periphery has the capacity to change microglial reactivity and to extend ALS survival. Nat. Neurosci. 2020;23:1339&#x2013;1351. doi: 10.1038/s41593-020-00718-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00718-z</ArticleId><ArticleId IdType="pubmed">33077946</ArticleId></ArticleIdList></Reference><Reference><Citation>Gois A.M., Mendon&#xe7;a D.M.F., Freire M.A.M., Santos J.R. In&#xa0;vitro and in&#xa0;vivo models of amyotrophic lateral sclerosis: an updated overview. Brain Res. Bull. 2020;159:32&#x2013;43. doi: 10.1016/j.brainresbull.2020.03.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresbull.2020.03.012</ArticleId><ArticleId IdType="pubmed">32247802</ArticleId></ArticleIdList></Reference><Reference><Citation>Liguori F., Amadio S., Volont&#xe9; C. Where and why modeling amyotrophic lateral sclerosis. Int. J. Mol. Sci. 2021;22:3977. doi: 10.3390/ijms22083977.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22083977</ArticleId><ArticleId IdType="pmc">PMC8070525</ArticleId><ArticleId IdType="pubmed">33921446</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z., Cheng X., Zhong S., Zhang X., Liu C., Liu F., Zhao C. Peripheral and central nervous system immune response crosstalk in amyotrophic lateral sclerosis. Front. Neurosci. 2020;14:575. doi: 10.3389/fnins.2020.00575.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00575</ArticleId><ArticleId IdType="pmc">PMC7308438</ArticleId><ArticleId IdType="pubmed">32612503</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xe9;land L.-C., Markovinovic A., Jakovac H., De Marchi F., Bilic E., Mazzini L., Kriz J., Munitic I. Immunity in amyotrophic lateral sclerosis: blurred lines between excessive inflammation and inefficient immune responses. Brain Commun. 2020;2:fcaa124. doi: 10.1093/braincomms/fcaa124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcaa124</ArticleId><ArticleId IdType="pmc">PMC7585698</ArticleId><ArticleId IdType="pubmed">33134918</ArticleId></ArticleIdList></Reference><Reference><Citation>A McCombe P., D Henderson R. The Role of immune and inflammatory mechanisms in ALS. Curr. Mol. Med. 2011;11:246&#x2013;254. doi: 10.2174/156652411795243450.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/156652411795243450</ArticleId><ArticleId IdType="pmc">PMC3182412</ArticleId><ArticleId IdType="pubmed">21375489</ArticleId></ArticleIdList></Reference><Reference><Citation>Riva N., Clarelli F., Domi T., Cerri F., Gallia F., Trimarco A., Brambilla P., Lunetta C., Lazzerini A., Lauria G., et al. Unraveling gene expression profiles in peripheral motor nerve from amyotrophic lateral sclerosis patients: insights into pathogenesis. Sci. Rep. 2016;6:39297. doi: 10.1038/srep39297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep39297</ArticleId><ArticleId IdType="pmc">PMC5159906</ArticleId><ArticleId IdType="pubmed">27982123</ArticleId></ArticleIdList></Reference><Reference><Citation>Gruntman A.M., Bish L.T., Mueller C., Sweeney H.L., Flotte T.R., Gao G. Gene transfer in skeletal and cardiac muscle using recombinant adeno-associated virus. Curr. Protoc. Microbiol. 2013 doi: 10.1002/9780471729259.mc14d03s28. Chapter 14, Unit 14D.3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/9780471729259.mc14d03s28</ArticleId><ArticleId IdType="pmc">PMC3641885</ArticleId><ArticleId IdType="pubmed">23408131</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauranzano E., Pozzi S., Pasetto L., Stucchi R., Massignan T., Paolella K., Mombrini M., Nardo G., Lunetta C., Corbo M., et al. Peptidylprolyl isomerase A governs TARDBP function and assembly in heterogeneous nuclear ribonucleoprotein complexes. Brain. 2015;138:974&#x2013;991. doi: 10.1093/brain/awv005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awv005</ArticleId><ArticleId IdType="pubmed">25678563</ArticleId></ArticleIdList></Reference><Reference><Citation>Friese A., Kaltschmidt J.A., Ladle D.R., Sigrist M., Jessell T.M., Arber S. Gamma and alpha motor neurons distinguished by expression of transcription factor Err3. Proc. Natl. Acad. Sci. U&#xa0;S&#xa0;A. 2009;106:13588&#x2013;13593. doi: 10.1073/pnas.0906809106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0906809106</ArticleId><ArticleId IdType="pmc">PMC2716387</ArticleId><ArticleId IdType="pubmed">19651609</ArticleId></ArticleIdList></Reference><Reference><Citation>Geuna S., Tos P., Guglielmone R., Battiston B., Giacobini-Robecchi M.G. Methodological issues in size estimation of myelinated nerve fibers in peripheral nerves. Anat. Embryol. 2001;204:1&#x2013;10. doi: 10.1007/s004290100188.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004290100188</ArticleId><ArticleId IdType="pubmed">11506429</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayeuf-Louchart A., Hardy D., Thorel Q., Roux P., Gueniot L., Briand D., Mazeraud A., Bougle A., Shorte S.L., Staels B., et al. MuscleJ: a high-content analysis method to study skeletal muscle with a new Fiji tool. Skelet. Muscle. 2018;8:25. doi: 10.1186/s13395-018-0171-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13395-018-0171-0</ArticleId><ArticleId IdType="pmc">PMC6091189</ArticleId><ArticleId IdType="pubmed">30081940</ArticleId></ArticleIdList></Reference><Reference><Citation>Bendotti C., Baldessari S., Pende M., Southgate T., Guglielmetti F., Samanin R. Relationship between GAP-43 expression in the dentate gyrus and synaptic reorganization of hippocampal mossy fibres in rats treated with kainic acid. Eur. J. Neurosci. 1997;9:93&#x2013;101. doi: 10.1111/j.1460-9568.1997.tb01357.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9568.1997.tb01357.x</ArticleId><ArticleId IdType="pubmed">9042573</ArticleId></ArticleIdList></Reference><Reference><Citation>Thacker J.S., Yeung D.H., Staines W.R., Mielke J.G. Total protein or high-abundance protein: which offers the best loading control for Western blotting? Anal. Biochem. 2016;496:76&#x2013;78. doi: 10.1016/j.ab.2015.11.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ab.2015.11.022</ArticleId><ArticleId IdType="pubmed">26706797</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph A.C., Bendotti C., Blaugrund E., Chio A., Greensmith L., Loeffler J.-P., Mead R., Niessen H.G., Petri S., Pradat P.F., et al. Guidelines for preclinical animal research in ALS/MND: a consensus meeting. Amyotroph. Lateral Scler. 2010;11:38&#x2013;45. doi: 10.3109/17482960903545334.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960903545334</ArticleId><ArticleId IdType="pubmed">20184514</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>